jobynimble
1週前
1606 CORP.
$400,000
20,000,000 SHARES OF COMMON STOCK
$0.02 PER SHARE
This is the offering of securities of 1606 Corp., a Nevada corporation (the “Company,” “CW,” “we,” “our” and “us”). We are offering for sale a total of 20,000,000 shares of our Common Stock at a fixed price of $0.02 per share (the “Shares”) in a “Tier 2 Offering” under Regulation A (the “Offering”).
The Offering will terminate at the earlier of: (1) the date at which 20,000,000 Shares have been sold, (2) the date which is one year after this Offering being qualified by the U.S. Securities and Exchange Commission (the “SEC” or the “Commission”), subject to a 90-day extension at the discretion of the Company, or (3) the date on which this Offering is earlier terminated by the Company in its sole discretion (the “Termination Date”). This Offering is being conducted on a “best efforts” basis without any minimum offering amount pursuant to Regulation A of Section 3(6) of the Securities Act of 1933, as amended (the “Securities Act”), for Tier 2 offerings.
The minimum investment amount for a single investor is in the cumulative principal amount of $500. Subscriptions are irrevocable and the purchase price is non-refundable, as expressly stated in this Offering Circular. The proceeds of this Offering will not be placed into an escrow account. As there is no minimum offering, upon the approval of any subscription to this Offering Circular, we shall immediately deposit said proceeds into our bank account and may utilize the proceeds immediately in accordance with the “Use of Proceeds.”
The Company, by determination of the board of directors of the Company, in its sole discretion, may issue Common Stock under this Offering for cash, promissory notes, services, and/or other consideration without notice to subscribers. The aggregate Offering price is to be based on the price at which the Common Stock is offered for cash. Any portion of the aggregate Offering price or aggregate sales attributable to cash received in a foreign currency will be translated into United States currency at a currency exchange rate in effect on, or at a reasonable time before, the date of the sale of the Common Stock. If the Common Stock is not sold for cash, the aggregate offering price or aggregate sales will be based on the value of the consideration as established by bona fide sales of that consideration made within a reasonable time, or, in the absence of sales, on the fair value as determined by an accepted standard. Valuations of non-cash consideration will be reasonable at the time made.
Our Chief Executive Officer, Austen Lambrecht, is the sole holder of our Series B Super Voting Preferred Stock (the “Series B Preferred Stock”), owns shares of Class A Preferred Stock, and owns shares of Common Stock. If at least one share of Series B Preferred Stock is issued and outstanding, then the total aggregate issued shares of Series B Preferred Stock at any given time, regardless of their number, have voting rights equal to 10 times the sum of: i) the total number of shares of Common Stock which are issued and outstanding at the time of voting, plus ii) the total number of votes of all other series of Preferred Stocks which are issued and outstanding at the time of voting. Due to his ownership of shares of Series B Preferred Stock, Mr. Lambrecht controls a majority of the voting power of our Company. For so long as each of Mr. Lambrecht holds all of the shares of Series B Preferred Stock he is expected to hold a majority of our issued and outstanding voting power and he will control the outcome of matters submitted to a stockholder vote, including the appointment of all directors of the Company.
Generally, in the case of trading on the over-the-counter markets, no sale may be made to you in this Offering if the aggregate purchase price you pay is more than 10% of the greater of your annual income or net worth (please see under How to Calculate Net Worth elsewhere in this Offering Circular). Different rules apply to accredited investors and non-natural persons. Before making any representation that your investment does not exceed applicable thresholds, we encourage you to review Rule 251(d)(2)(i)(C) of Regulation A. For general information on investing, we encourage you to refer to www.investor.gov.
Full filing: https://www.sec.gov/Archives/edgar/data/1877461/000147793224008312/onesix_253g1.htm
stocktowatch
2週前
Good morning $CBDW and Its AI Chatbot Revolutionizing Customer Engagement for Public Companies
In a rapidly evolving business landscape, customer service and engagement are pivotal for the success of public companies. However, recent surveys have revealed a troubling gap in the market, with many investors and stakeholders expressing dissatisfaction over the lack of accessible and efficient support when researching public companies. Enter 1606 Corporation (CBDW), a forward-thinking technology company that is transforming the way public companies interact with their customers through its innovative AI-powered chatbot.
The Market Gap: A Survey of Investor Sentiment
A recent survey conducted among investors and stakeholders revealed a striking dissatisfaction with the current level of support available for those researching public companies. A significant portion of participants reported feeling frustrated with the limited access to timely information and the absence of immediate assistance when seeking answers about a company’s financials, corporate governance, or other essential data. The lack of responsive and efficient customer service options when navigating complex public company data is a pain point that has remained largely unaddressed—until now.
The survey underscores a broader issue: as public companies grow in size and complexity, they often struggle to provide personalized, real-time support for the increasing volume of questions they receive from analysts, investors, and the general public. This challenge is particularly acute when dealing with intricate financial documents, regulatory filings, and shareholder concerns, which require quick and accurate responses.
1606 Corporation’s AI Chatbot: A Solution to the Market’s Needs
Recognizing the need for a better approach, 1606 Corporation has developed an AI-powered chatbot designed to fill this critical gap. The company’s advanced technology is tailor-made for public companies, enabling them to provide immediate, accurate, and accessible support to a diverse range of stakeholders. The AI chatbot is capable of answering a wide array of questions related to corporate data, financial reports, governance policies, investor relations, and more—all through a simple and intuitive interface.
What makes the 1606 Corporation’s chatbot particularly revolutionary is its ability to handle complex queries efficiently, without the need for human intervention. Whether a user is seeking the latest quarterly earnings, information about the company’s board of directors, or insight into regulatory filings, the chatbot can provide these answers instantaneously. This is a game-changer for public companies that need to manage large volumes of inquiries without sacrificing the quality or speed of their customer service.
Enhancing Customer Service and Engagement
The integration of AI into customer service is not just about reducing costs—it’s about improving the overall experience for investors and other stakeholders. The chatbot’s 24/7 availability means that individuals can get the information they need at any time, without waiting for office hours or dealing with long response times. This level of accessibility can be especially beneficial for investors across different time zones or those managing large portfolios with tight decision-making timelines.
Moreover, the AI chatbot provides a seamless and personalized experience, learning from interactions to improve responses over time. By utilizing natural language processing (NLP) and machine learning algorithms, the chatbot can understand and process complex queries, providing more nuanced answers based on user intent. This continual learning process ensures that the chatbot evolves alongside a company’s needs and the changing demands of its stakeholders.
Driving Efficiency and Accessibility in Public Companies
1606 Corporation’s AI technology is not just enhancing customer service; it is also driving a new era of efficiency for public companies. Traditionally, managing inquiries from investors, analysts, and the public required significant manpower and time. With the AI chatbot, public companies can offload routine questions and tasks, freeing up their staff to focus on higher-priority matters. This streamlined approach not only saves time but also reduces operational costs, making it easier for public companies to scale their customer service efforts as they grow.
Additionally, the chatbot’s ability to present data in an easily digestible format improves accessibility. Financial reports and other complex information can be difficult to interpret for individuals without a deep understanding of the underlying data. The AI chatbot can break down these details in a more user-friendly way, helping investors and stakeholders gain clarity on important company metrics.
The Future of Customer Engagement in Public Companies
As AI continues to advance, 1606 Corporation is positioned at the forefront of a significant shift in how public companies engage with their customers. The company’s AI chatbot technology is not only addressing a key market gap but also setting a new standard for how companies should interact with their investors and stakeholders. The potential benefits of this technology are immense, from improving operational efficiency and customer satisfaction to fostering greater transparency and trust in the information shared by public companies.
In conclusion, 1606 Corporation (CBDW) is leading the charge in transforming customer service for public companies with its cutting-edge AI chatbot. By bridging the gap in support and engagement highlighted by recent surveys, 1606 is helping public companies offer faster, more accessible, and more personalized interactions with investors and stakeholders. This innovative technology is paving the way for a more efficient and transparent future in the corporate world, where AI and human expertise work together to drive success.
ProfitScout
2週前
This week's news from CBDW covering the great promise from their involvement with and investment plans for Adnexus Biotechnologies is impressive. The emerging AI technologies in the advancement of medical applications can lead to unparalleled benefits for so may people and businesses.
--------------------------------------------------------------------------------------------------
1606 Corp. Expresses Strong Support for Adnexus Biotechnologies' Groundbreaking AI Technology
SEATTLE, WA / ACCESSWIRE / December 18, 2024 / 1606 Corp. (OTC Pink:CBDW) is pleased to issue a statement in support of Adnexus Biotechnologies Inc., following the company's recent announcement of its revolutionary Neural Temporal Fingerprinting technology for personalized health monitoring. As part of our ongoing strategic partnership, 1606 Corp. recognizes the transformative potential of Adnexus' AI-driven advancements and looks forward to the continued development of these innovative solutions.
Adnexus' Groundbreaking Innovation
The Neural Temporal Fingerprinting technology introduced by Adnexus leverages AI-driven analysis of EEG and ECG signals to deliver unparalleled insights into neurological and cardiovascular health. Key aspects of the technology include:
Neurological Prediction: AI-powered analysis of EEG data to detect early signs of neurological conditions such as Alzheimer's, Parkinson's, and PTSD.
Cardiovascular Risk Assessment: Analyzing ECG signals to assess heart health, identify arrhythmias, and predict risks of heart failure and myocardial infarction.
Integrated EEG/ECG Analysis: Merging both neurological and cardiovascular data to better understand the complex interplay between brain and heart health.
Enhanced PTSD Detection: Identifying emotional and autonomic dysregulations to provide more effective treatments for trauma survivors.
1606 Corp. views Adnexus' breakthrough as a critical step in the future of personalized medicine and real-time health monitoring, particularly as wearables become an increasingly integral part of healthcare. We believe this innovation will significantly disrupt the growing AI-driven healthcare market, positioning both Adnexus and 1606 Corp. for future success.
Austen Lambrecht, CEO of 1606 Corp., commented:
"Adnexus' latest development in Neural Temporal Fingerprinting is a powerful demonstration of the company's ability to drive innovation in the healthcare sector. As a strategic partner, we are excited to support Adnexus in bringing this groundbreaking technology to market. We see tremendous potential for these AI-powered solutions to redefine the way neurological and cardiovascular conditions are diagnosed and treated, and we look forward to continuing our collaboration with Adnexus in this transformative space."
Commitment to Innovation and Growth
The potential strategic investment by 1606 Corp. in Adnexus aligns with our long-term vision to invest in cutting-edge AI health technologies that are poised for significant growth. Adnexus previously signed a Letter of Intent with 1606 Corp. for a strategic investment by 1606 Corp. in Adnexus. The LOI terminated on November 28, 2024 but the parties are still moving forward to close the transaction. We are confident that Adnexus' focus on AI-driven diagnostic tools and personalized health insights will play an essential role in advancing healthcare practices and improving patient outcomes.
About 1606 Corp.
1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.
As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.
For more information, please visit cbdw.ai.
Industry Information
The global AI market, valued at $428 billion in 2022, is anticipated to reach $2.25 trillion by 2030, with a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%. The sector is expected to employ 97 million individuals by 2025[1], reflecting its expansive and significant impact. This potential growth presents a compelling opportunity for investors and industry professionals interested in the AI sector.
The global wearable health technology market was valued at $70.3 billion in 2024 and is projected to reach $152.8 billion by 2029, growing at a CAGR of 16.4%[2]. This growth is driven by advancements in sensor technology, AI integration, and increasing consumer demand for real-time health monitoring. Adnexus' emphasis on continuous health monitoring through wearable devices aligns directly with this market trend, particularly as consumers and healthcare providers look for tools to proactively manage chronic conditions and predict health risks.
AI-Powered Wearables: Wearable health devices powered by AI are increasingly being used to monitor vital signs such as heart rate, blood pressure, ECG, and EEG. Adnexus' hybrid model combining EEG and ECG for continuous health monitoring could place it in a strong position within the rapidly growing wearable health tech market.
The global AI in healthcare market was valued at $11.8 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 37.2% from 2023 to 2030[3]. This growth is driven by the increasing demand for advanced diagnostic tools, predictive analytics, and personalized treatments, which align with Adnexus' focus on AI-powered health insights through EEG and ECG data.
Forward-Looking Statements
This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.
Contact Information
Austen Lambrecht
CEO
austen@1606corp.com
[1]MarketsandMarkets, "Artificial Intelligence Market by Technology (Machine Learning, NLP, Computer Vision), End-User Industry (Healthcare, BFSI, Automotive, Retail, IT & Telecom), and Region - Global Forecast to 2030," 2023; PwC, "Global Artificial Intelligence Study: Exploiting the AI Revolution," 2022; McKinsey & Company, "The State of AI in 2023," 2023.
[2] Grand View Research, "Wearable Medical Devices Market Size, Share & Trends Analysis Report by Product (Smartwatches, Fitness Bands, Patches), by Application (Cardiovascular, Sleep Monitoring), by Region, and Segment Forecasts, 2024 - 2029," 2023; Statista, "Global Wearable Health Technology Market Value Forecast," 2023; Frost & Sullivan, "Wearable Health Tech: The Next Frontier in Healthcare Innovation," 2023.
[3] Fortune Business Insights, "Artificial Intelligence in Healthcare Market Size, Share & Trends Analysis Report by Offering, by Technology, by Application, by End User, and Segment Forecasts, 2023 - 2030," 2023; ResearchAndMarkets, "AI in Healthcare Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2023 - 2030," 2023; Grand View Research, "Artificial Intelligence in Healthcare Market Size, Share & Trends Analysis Report by Technology (Machine Learning, Natural Language Processing), by Application (Diagnostics, Drug Discovery), by End-Use, and Segment Forecasts, 2023 - 2030," 2023.
SOURCE: 1606 Corp.
View the original press release on accesswire.com